ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 1,503 | 1,505 | 1,453 | 1,458 | -37 | -2.5% | 3,093,200 |
| 2024/04/25 | 1,496 | 1,534 | 1,493 | 1,495 | -13 | -0.9% | 731,300 |
| 2024/04/24 | 1,488 | 1,519 | 1,481 | 1,508 | +28 | +1.9% | 708,600 |
| 2024/04/23 | 1,477 | 1,489 | 1,463 | 1,480 | +13 | +0.9% | 584,900 |
| 2024/04/22 | 1,466 | 1,482 | 1,457 | 1,467 | +17 | +1.2% | 602,200 |
| 2024/04/19 | 1,499 | 1,505 | 1,448 | 1,450 | -61 | -4% | 1,064,700 |
| 2024/04/18 | 1,480 | 1,529 | 1,474 | 1,511 | +48 | +3.3% | 762,900 |
| 2024/04/17 | 1,516 | 1,552 | 1,463 | 1,463 | +7 | +0.5% | 1,376,800 |
| 2024/04/16 | 1,485 | 1,492 | 1,451 | 1,456 | -57 | -3.8% | 891,700 |
| 2024/04/15 | 1,488 | 1,529 | 1,470 | 1,513 | +13 | +0.9% | 950,200 |
| 2024/04/12 | 1,530 | 1,537 | 1,463 | 1,500 | -60 | -3.8% | 1,773,000 |
| 2024/04/11 | 1,571 | 1,595 | 1,554 | 1,560 | -31 | -1.9% | 899,800 |
| 2024/04/10 | 1,608 | 1,620 | 1,571 | 1,591 | -31 | -1.9% | 772,800 |
| 2024/04/09 | 1,627 | 1,642 | 1,599 | 1,622 | +73 | +4.7% | 1,736,500 |
| 2024/04/08 | 1,544 | 1,567 | 1,531 | 1,549 | +15 | +1% | 759,100 |
| 2024/04/05 | 1,530 | 1,541 | 1,483 | 1,534 | -36 | -2.3% | 1,245,800 |
| 2024/04/04 | 1,550 | 1,583 | 1,538 | 1,570 | +26 | +1.7% | 720,300 |
| 2024/04/03 | 1,543 | 1,558 | 1,503 | 1,544 | -13 | -0.8% | 1,046,700 |
| 2024/04/02 | 1,614 | 1,616 | 1,547 | 1,557 | -81 | -4.9% | 1,057,000 |
| 2024/04/01 | 1,660 | 1,667 | 1,610 | 1,638 | -24 | -1.4% | 824,600 |
| 2024/03/29 | 1,626 | 1,670 | 1,626 | 1,662 | +41 | +2.5% | 950,200 |
| 2024/03/28 | 1,627 | 1,652 | 1,603 | 1,621 | +19 | +1.2% | 990,700 |
| 2024/03/27 | 1,618 | 1,627 | 1,578 | 1,602 | -12 | -0.7% | 1,054,800 |
| 2024/03/26 | 1,574 | 1,637 | 1,563 | 1,614 | +36 | +2.3% | 1,128,900 |
| 2024/03/25 | 1,589 | 1,622 | 1,577 | 1,578 | -12 | -0.8% | 736,100 |
| 2024/03/22 | 1,596 | 1,604 | 1,559 | 1,590 | -4 | -0.3% | 753,600 |
| 2024/03/21 | 1,579 | 1,596 | 1,565 | 1,594 | +53 | +3.4% | 1,286,100 |
| 2024/03/19 | 1,567 | 1,570 | 1,532 | 1,541 | -18 | -1.2% | 608,100 |
| 2024/03/18 | 1,518 | 1,564 | 1,515 | 1,559 | +50 | +3.3% | 1,096,300 |
| 2024/03/15 | 1,525 | 1,537 | 1,483 | 1,509 | -51 | -3.3% | 1,550,700 |
| 2024/03/14 | 1,550 | 1,586 | 1,530 | 1,560 | +3 | +0.2% | 980,200 |
| 2024/03/13 | 1,592 | 1,592 | 1,529 | 1,557 | -25 | -1.6% | 1,615,500 |
| 2024/03/12 | 1,615 | 1,649 | 1,560 | 1,582 | -153 | -8.8% | 5,022,800 |
| 2024/03/11 | 1,770 | 1,780 | 1,707 | 1,735 | -53 | -3% | 1,905,400 |
| 2024/03/08 | 1,671 | 1,826 | 1,664 | 1,788 | +126 | +7.6% | 4,810,300 |
| 2024/03/07 | 1,606 | 1,662 | 1,570 | 1,662 | +65 | +4.1% | 2,001,600 |
| 2024/03/06 | 1,500 | 1,599 | 1,497 | 1,597 | +82 | +5.4% | 2,009,700 |
| 2024/03/05 | 1,469 | 1,546 | 1,457 | 1,515 | +29 | +2% | 1,103,400 |
| 2024/03/04 | 1,535 | 1,540 | 1,484 | 1,486 | -64 | -4.1% | 1,202,800 |
| 2024/03/01 | 1,450 | 1,561 | 1,450 | 1,550 | +94 | +6.5% | 3,123,900 |
| 2024/02/29 | 1,454 | 1,464 | 1,423 | 1,456 | +5 | +0.3% | 749,500 |
| 2024/02/28 | 1,435 | 1,480 | 1,429 | 1,451 | +17 | +1.2% | 1,330,900 |
| 2024/02/27 | 1,424 | 1,434 | 1,388 | 1,434 | +4 | +0.3% | 1,185,400 |
| 2024/02/26 | 1,425 | 1,448 | 1,406 | 1,430 | -3 | -0.2% | 879,200 |
| 2024/02/22 | 1,410 | 1,436 | 1,386 | 1,433 | +14 | +1% | 1,013,500 |
| 2024/02/21 | 1,429 | 1,449 | 1,416 | 1,419 | -20 | -1.4% | 848,200 |
| 2024/02/20 | 1,399 | 1,446 | 1,393 | 1,439 | +57 | +4.1% | 1,799,800 |
| 2024/02/19 | 1,336 | 1,397 | 1,327 | 1,382 | +42 | +3.1% | 1,323,100 |
| 2024/02/16 | 1,332 | 1,344 | 1,313 | 1,340 | +23 | +1.7% | 1,572,400 |
| 2024/02/15 | 1,402 | 1,415 | 1,304 | 1,317 | -80 | -5.7% | 2,397,900 |
1～
50
件表示中 / 4835件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 145,800円 | +150.7% | - | 0.00% | 37.26倍 | 1.95倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 科研薬 | 340,700円 | +0.2% | -8.3% | 4.40% | 19.26倍 | 0.92倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 277,300円 | +9.6% | +279.3% | 2.16% | 10.50倍 | 0.93倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ジーエヌアイ | 251,000円 | +52.1% | +23.3% | 0.00% | 17.74倍 | 3.70倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| 杏林製薬 | 182,800円 | +2.6% | +11.5% | 2.84% | 21.43倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
